Benzinga | Nov 10, 2021 07:33AM EST

Precision BioSciences Q3 EPS $(0.19) Beats $(0.59) Estimate, Sales $24.04M Beat $6.02M Estimate

Precision BioSciences (NASDAQ:DTIL) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.59) by 67.8 percent. This is a 62 percent increase over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $24.04 million which beat the analyst consensus estimate of $6.02 million by 299.27 percent. This is a 226.44 percent increase over sales of $7.36 million the same period last year.